509 related articles for article (PubMed ID: 32252351)
1. Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK.
Moldogazieva NT; Mokhosoev IM; Terentiev AA
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32252351
[TBL] [Abstract][Full Text] [Related]
2. Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation.
Yu L; Lu M; Jia D; Ma J; Ben-Jacob E; Levine H; Kaipparettu BA; Onuchic JN
Cancer Res; 2017 Apr; 77(7):1564-1574. PubMed ID: 28202516
[TBL] [Abstract][Full Text] [Related]
3. Metabolic evolutionary roots of the macrophage immune response in amoeba-bacteria interactions: The conserved role of hypoxia-induced Factor and AMP kinase.
Dzik J
Acta Biochim Pol; 2021 Aug; 68(3):457-476. PubMed ID: 34374500
[TBL] [Abstract][Full Text] [Related]
4. Lactic Acidosis in the Presence of Glucose Diminishes Warburg Effect in Lung Adenocarcinoma Cells.
Prado-Garcia H; Campa-Higareda A; Romero-Garcia S
Front Oncol; 2020; 10():807. PubMed ID: 32596143
[TBL] [Abstract][Full Text] [Related]
5. p53 and glucose metabolism: an orchestra to be directed in cancer therapy.
Gomes AS; Ramos H; Soares J; Saraiva L
Pharmacol Res; 2018 May; 131():75-86. PubMed ID: 29580896
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
Tyszka-Czochara M; Konieczny P; Majka M
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53
Hernández-Reséndiz I; Gallardo-Pérez JC; López-Macay A; Robledo-Cadena DX; García-Villa E; Gariglio P; Saavedra E; Moreno-Sánchez R; Rodríguez-Enríquez S
J Cell Physiol; 2019 May; 234(5):5524-5536. PubMed ID: 30272821
[TBL] [Abstract][Full Text] [Related]
8. The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator.
Faubert B; Vincent EE; Poffenberger MC; Jones RG
Cancer Lett; 2015 Jan; 356(2 Pt A):165-70. PubMed ID: 24486219
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the Warburg effect: historical dogma versus current understanding.
Vaupel P; Multhoff G
J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells.
Jung SN; Yang WK; Kim J; Kim HS; Kim EJ; Yun H; Park H; Kim SS; Choe W; Kang I; Ha J
Carcinogenesis; 2008 Apr; 29(4):713-21. PubMed ID: 18258605
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells.
Lee M; Hwang JT; Lee HJ; Jung SN; Kang I; Chi SG; Kim SS; Ha J
J Biol Chem; 2003 Oct; 278(41):39653-61. PubMed ID: 12900407
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of p53 regulation of oxidative stress in skeletal muscle.
Beyfuss K; Hood DA
Redox Rep; 2018 Dec; 23(1):100-117. PubMed ID: 29298131
[TBL] [Abstract][Full Text] [Related]
13. Ablation of CD44 induces glycolysis-to-oxidative phosphorylation transition via modulation of the c-Src-Akt-LKB1-AMPKα pathway.
Nam K; Oh S; Shin I
Biochem J; 2016 Oct; 473(19):3013-30. PubMed ID: 27458252
[TBL] [Abstract][Full Text] [Related]
14. Acetylation mediated by the p300/CBP-associated factor determines cellular energy metabolic pathways in cancer.
Rajendran R; Garva R; Ashour H; Leung T; Stratford I; Krstic-Demonacos M; Demonacos C
Int J Oncol; 2013 Jun; 42(6):1961-72. PubMed ID: 23591450
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
16. Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells - A potential contribution to the predictive, preventive, and personalized medicine.
Mazurakova A; Koklesova L; Csizmár SH; Samec M; Brockmueller A; Šudomová M; Biringer K; Kudela E; Pec M; Samuel SM; Kassayova M; Hassan STS; Smejkal K; Shakibaei M; Büsselberg D; Saso L; Kubatka P; Golubnitschaja O
J Adv Res; 2024 Jan; 55():103-118. PubMed ID: 36871616
[TBL] [Abstract][Full Text] [Related]
17. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
18. Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
Jia D; Lu M; Jung KH; Park JH; Yu L; Onuchic JN; Kaipparettu BA; Levine H
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3909-3918. PubMed ID: 30733294
[TBL] [Abstract][Full Text] [Related]
19. HIF-1α pathway: role, regulation and intervention for cancer therapy.
Masoud GN; Li W
Acta Pharm Sin B; 2015 Sep; 5(5):378-89. PubMed ID: 26579469
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]